Beirne Wealth Consulting Services, LLC Exact Sciences Corp Transaction History

Beirne Wealth Consulting Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$72.5 - $100.68 $173,492 - $240,927	-2,393 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$93.66 - $139.27 $655 - $974	-7 Reduced 0.29%	2,393 $297,000
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $196,070 - $260,726	-1,682 Reduced 41.21%	2,400 $316,000
Q4 2020 Feb 03, 2021	BUY	$99.61 - $142.12 $1,693 - $2,416	17 Added 0.42%	4,082 $541,000
Q3 2020 Nov 05, 2020	BUY	$72.92 - $102.01 $121,411 - $169,846	1,665 Added 69.38%	4,065 $414,000
Q2 2020 Jul 31, 2020	BUY	$55.75 - $92.75 $133,800 - $222,600	2,400 New	2,400 $209,000
Q1 2020 Apr 28, 2020	SELL	$37.9 - $104.44 $90,960 - $250,656	-2,400 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$89.51 - $118.04 $57,375 - $75,663	-641 Reduced 21.08%	2,400 $283,000
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $188,481 - $293,456	3,041 New	3,041 $263,000

671

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.